EcoDrugPlus

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSPTIG00000019749
Gene Symbol: MST1R
2 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSPTIG00000007791
Gene Symbol: MGAM
2 Cross references
312 Possible Orthologues:

Maltase-Glucoamylase 2 (Putative)

Ensembl ID : ENSPTIG00000007875
Gene Symbol: MGAM2
2 Cross references
390 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSPTIG00000008353
Gene Symbol: MMP1
2 Cross references
352 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSPTIG00000008238
Gene Symbol: MMP12
2 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSPTIG00000008043
Gene Symbol: MMP13
2 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSPTIG00000018375
Gene Symbol: MMP14
1 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSPTIG00000020638
Gene Symbol: MMP2
2 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSPTIG00000008284
Gene Symbol: MMP3
2 Cross references
491 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSPTIG00000008931
Gene Symbol: MMP7
2 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSPTIG00000008615
Gene Symbol: MMP8
2 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSPTIG00000021612
Gene Symbol: MMP9
2 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).